• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门球时间小于或大于60分钟的直接经皮冠状动脉介入治疗的医院结局:一项前瞻性观察研究。

In Hospital Outcome of Primary PCI With Door to Balloon Time Less or More Than 60 Min: A Prospective Observational Study.

作者信息

Zahidi Muzaffar Ali, Iqbal Sadia, Anjum Muhammad, Anber Nabila, Iqbal Minahil

机构信息

Punjab Institute of Cardiology (PIC), Lahore, Pakistan.

Gujranwala Medical College, Gujranwala, Pakistan.

出版信息

Catheter Cardiovasc Interv. 2025 Jul;106(1):263-268. doi: 10.1002/ccd.31541. Epub 2025 Apr 17.

DOI:10.1002/ccd.31541
PMID:40247449
Abstract

INTRODUCTION

Timely primary percutaneous coronary intervention (PCI) is crucial for optimal outcomes in STEMI patients, with guidelines recommending door-to-balloon time (DTB) of less than 90 min. Reducing DTB times may improve clinical outcomes, but the necessity of further reductions is debated.

OBJECTIVE

Our study investigates the in-hospital outcomes of Acute STEMI patients with DTB of less than 60 min versus 60 or more minutes, aiming to determine whether further reducing DTB times is necessary.

METHODS

A single-center prospective observational study was conducted from March 1 to September 30, 2023. The study included patients presenting with acute STEMI who underwent primary PCI within the specified time frame. Statistical analysis was performed using SPSS Version 20.0, with descriptive statistics and inferential tests (chi-square, independent sample t-test) used to analyse the data, considering a p < 0.05 as statistically significant.

RESULTS

The study enrolled a total of 531 patients with Group-I (< 60 min) having 262 patients, and Group-II (>60 min) with 269 patients. The mean age was 52 years (90% males). Comorbidities, such as diabetes mellitus, smoking, hypertension, and family history of CAD, were similarly distributed between groups. In terms of outcomes, Group-I had better results, with 128 patients achieving TIMI-III flow, compared to 113 in Group-II. Group-I also had lower rates of myocardial infarction (0 vs. 2), shock (7 vs. 8), and heart failure (2 vs. 5). Notably, the mortality rate was 0 in Group-I, compared to 5 in Group-II, however all complications in terms of death or morbidity were statistically non-significant in both groups. Other outcomes, such as bleeding events, hematoma, and cerebrovascular accidents, were also low and similar between groups.

CONCLUSIONS

The results showed that both groups had similar patient characteristics, including age, gender, and comorbidities, with adverse events, such as acute stent thrombosis, myocardial infarction, and mortality, were generally low and similar between groups.

摘要

引言

及时进行直接经皮冠状动脉介入治疗(PCI)对于ST段抬高型心肌梗死(STEMI)患者获得最佳治疗效果至关重要,指南建议门球时间(DTB)少于90分钟。缩短DTB时间可能会改善临床结局,但进一步缩短时间的必要性仍存在争议。

目的

我们的研究调查了DTB少于60分钟与60分钟及以上的急性STEMI患者的院内结局,旨在确定是否有必要进一步缩短DTB时间。

方法

于2023年3月1日至9月30日进行了一项单中心前瞻性观察研究。该研究纳入了在特定时间范围内接受直接PCI的急性STEMI患者。使用SPSS 20.0进行统计分析,采用描述性统计和推断性检验(卡方检验、独立样本t检验)分析数据,将p<0.05视为具有统计学意义。

结果

该研究共纳入531例患者,其中第一组(<60分钟)有262例患者,第二组(>60分钟)有269例患者。平均年龄为52岁(90%为男性)。糖尿病、吸烟、高血压和CAD家族史等合并症在两组间分布相似。在结局方面,第一组结果更好,128例患者达到TIMI-III血流,而第二组为113例。第一组的心肌梗死发生率(0例 vs. 2例)、休克发生率(7例 vs. 8例)和心力衰竭发生率(2例 vs. 5例)也更低。值得注意的是,第一组的死亡率为0,而第二组为5例,然而两组在死亡或发病方面的所有并发症在统计学上均无显著差异。其他结局,如出血事件、血肿和脑血管意外,发生率也较低且两组相似。

结论

结果表明,两组患者特征相似,包括年龄、性别和合并症,急性支架血栓形成、心肌梗死和死亡率等不良事件总体发生率较低且两组相似。

相似文献

1
In Hospital Outcome of Primary PCI With Door to Balloon Time Less or More Than 60 Min: A Prospective Observational Study.门球时间小于或大于60分钟的直接经皮冠状动脉介入治疗的医院结局:一项前瞻性观察研究。
Catheter Cardiovasc Interv. 2025 Jul;106(1):263-268. doi: 10.1002/ccd.31541. Epub 2025 Apr 17.
2
Door-to-Balloon Time and Clinical Outcome of Patients Presenting with ST-Segment Elevation Myocardial Infarction During on and off Hours: a Single Center Study.ST段抬高型心肌梗死患者在工作时间和非工作时间的门球时间及临床结局:一项单中心研究
Med Arch. 2025;79(3):172-180. doi: 10.5455/medarh.2025.79.172-180.
3
Assessing angiographic results of saline autotransfusion and thrombus aspiration in STEMI patients.评估ST段抬高型心肌梗死患者自体盐水输注及血栓抽吸的血管造影结果。
Future Cardiol. 2025 Mar;21(4):237-243. doi: 10.1080/14796678.2025.2472581. Epub 2025 Mar 4.
4
Comparing FFR-Guided Complete Revascularization and Conservative Management for Non-Culprit Lesions in STEMI Patients With Multivessel Disease: A Systematic Review and Meta-Analysis.比较FFR指导的完全血运重建与保守治疗对多支血管病变STEMI患者非罪犯病变的疗效:一项系统评价和荟萃分析
Catheter Cardiovasc Interv. 2025 Feb;105(3):633-642. doi: 10.1002/ccd.31379. Epub 2024 Dec 24.
5
Preoperative coronary interventions for preventing acute myocardial infarction in the perioperative period of major open vascular or endovascular surgery.术前冠状动脉介入治疗预防大型开放性血管或血管内手术后围手术期急性心肌梗死。
Cochrane Database Syst Rev. 2024 Jul 3;7(7):CD014920. doi: 10.1002/14651858.CD014920.pub2.
6
Comparative Benefits of Primary Percutaneous Coronary Intervention Versus Onsite Fibrinolytic for Patients With ST-Segment-Elevation Myocardial Infarction: A Quasi-Experimental Study.ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗与现场溶栓治疗的比较效益:一项准实验研究。
J Am Heart Assoc. 2025 Jun 23:e041995. doi: 10.1161/JAHA.125.041995.
7
Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.ST段抬高型心肌梗死合并多支血管病变时完全血运重建与仅罪犯血管血运重建的比较
Cochrane Database Syst Rev. 2017 May 3;5(5):CD011986. doi: 10.1002/14651858.CD011986.pub2.
8
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
9
Timeliness of reperfusion in ST-segment elevation myocardial infarction and outcomes in Kerala, India: results of the TRUST outcomes registry.印度喀拉拉邦ST段抬高型心肌梗死再灌注的及时性及预后:TRUST预后登记研究结果
Postgrad Med J. 2025 Feb 19;101(1193):232-239. doi: 10.1093/postmj/qgae129.
10
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.